Slide background

Accurate and sensitive
detection of disease in
their initial stage

Read more

Latest from us


Recently QVQ has decided to invest in Orthros TR, a company that will develop bi-functional VHH to cure Osteoarthritis.

Other news


QVQ’s imaging agents are suitable for correlative imaging from nanometer to meter scale. (animation by ScienceTransmitter) 

QVQ is a company performing Contract Research for industrial partners and works together with Universities and medical centres in Collaboration Agreements.

QVQ provides expertise in each step of Llama Antibody Technology [VHH Technology], from immunizations, selections and screening of functionalities to production.

QVQ has a considerable number of high quality VHH for Sales for Research in areas like Cancer, Age related Diseases and Infectious Diseases

QVQ mission

QVQ contributes to the accurate and sensitive detection of diseases in the early stages by providing top quality validated Imaging and Research Agents based on their C-direct labelled single domain antibodies from camelids (professionally called functionalized VHH).

To become a supplier of top-end market products, QVQ closely works together with top academic and industrial groups and actively stimulates research in these areas.

Read more